These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21465533)

  • 1. Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin α9.
    Ou J; Li J; Pan F; Xie G; Zhou Q; Huang H; Liang H
    J Cell Biochem; 2011 Aug; 112(8):2106-14. PubMed ID: 21465533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal tumor derived fibronectin alternatively spliced EDA domain exserts lymphangiogenic effect on human lymphatic endothelial cells.
    Ou JJ; Wu F; Liang HJ
    Cancer Biol Ther; 2010 Feb; 9(3):186-91. PubMed ID: 20023414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
    Xiang L; Xie G; Ou J; Wei X; Pan F; Liang H
    PLoS One; 2012; 7(4):e35378. PubMed ID: 22496919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
    Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.
    Ou J; Deng J; Wei X; Xie G; Zhou R; Yu L; Liang H
    Stem Cell Res; 2013 Sep; 11(2):820-33. PubMed ID: 23811539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
    Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ
    J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
    Yokoyama Y; Ramakrishnan S
    Int J Cancer; 2007 Dec; 121(11):2402-9. PubMed ID: 17597104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The β
    Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes in a renal cell carcinoma tumor model after endostatin-treatment.
    van Wijngaarden J; de Rooij K; van Beek E; Bernsen H; Que I; van Hinsbergh VW; Löwik C
    Lab Invest; 2004 Nov; 84(11):1472-83. PubMed ID: 15273700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin specifically targets both tumor blood vessels and lymphatic vessels.
    Zhuo W; Chen Y; Song X; Luo Y
    Front Med; 2011 Dec; 5(4):336-40. PubMed ID: 22198745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
    Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
    Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    Zhang K; Wang Y; Yu X; Shi Y; Yao Y; Wei X; Ma X
    BMC Cancer; 2017 Dec; 17(1):899. PubMed ID: 29282026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
    Mishima K; Watabe T; Saito A; Yoshimatsu Y; Imaizumi N; Masui S; Hirashima M; Morisada T; Oike Y; Araie M; Niwa H; Kubo H; Suda T; Miyazono K
    Mol Biol Cell; 2007 Apr; 18(4):1421-9. PubMed ID: 17287396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
    Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
    Nishino K; Yoshimatsu Y; Muramatsu T; Sekimoto Y; Mitani K; Kobayashi E; Okamoto S; Ebana H; Okada Y; Kurihara M; Suzuki K; Inazawa J; Takahashi K; Watabe T; Seyama K
    Sci Rep; 2021 Apr; 11(1):8406. PubMed ID: 33863980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.